SG Biotechnology & Medical Research

CytoMed Therapeutics Ltd (GDTC)

Track

CytoMed Therapeutics recorded four insider trading transactions recently, totaling approximately 428,221 USD in volume. Activity reflects a net selling trend, primarily driven by a major stockholder, mDR Ltd, executing proposed sales. These movements occurred alongside a 6% stock price increase over the last quarter, following the company's latest June 2026 earnings report.
Ticker: GDTC Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
mDR Ltd 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
122.93
Quantity 88,840
Value US$1,716,864
Choo Chee Kong Non-Executive Director Large shareholder
Transaction date
Purchase
Price
470.33
Quantity 77,587 +49.2%
Value US$2,843,569
mDR LTD 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
268.74
Quantity 56,523
Value US$3,412,244
mDR LTD 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
0.84
Quantity 117,337
Value US$98,094
mDR LTD 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
1.04
Quantity 117,337
Value US$122,030
mDR Ltd 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
1.88
Quantity 54,644
Value US$102,731
mDR Ltd 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
2.10
Quantity 81,482
Value US$171,112
mDR Ltd 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
2.66
Quantity 86,410
Value US$229,850
mDR Ltd 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
2.31
Quantity 115,400
Value US$265,997
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-11 2026-08-11 PrS Proposed sale
mDR Ltd

10% Stockholder

Large shareholder
88,840
122.93
US$1,716,864 		88,840 122.93 US$1,716,864
2026-06-15 2026-05-13 B Purchase
Choo Chee Kong
Non-Executive Director Large shareholder
77,587 +49.2%
470.33
US$2,843,569 		77,587 +49.2% 470.33 US$2,843,569
2026-05-13 2026-05-13 PrS Proposed sale
mDR LTD

10% Stockholder

Large shareholder
56,523
268.74
US$3,412,244 		56,523 268.74 US$3,412,244
2026-05-13 2026-05-13 PrS Proposed sale
mDR LTD

10% Stockholder

Large shareholder
117,337
0.84
US$98,094 		117,337 0.84 US$98,094
2026-02-12 2026-02-12 PrS Proposed sale
mDR LTD

10% Stockholder

Large shareholder
117,337
1.04
US$122,030 		117,337 1.04 US$122,030
2025-09-22 2025-09-23 PrS Proposed sale
mDR Ltd

10% Stockholder

Large shareholder
54,644
1.88
US$102,731 		54,644 1.88 US$102,731
2025-06-23 2025-06-23 PrS Proposed sale
mDR Ltd

10% Stockholder

Large shareholder
81,482
2.10
US$171,112 		81,482 2.10 US$171,112
2025-03-24 2025-03-24 PrS Proposed sale
mDR Ltd

10% Stockholder

Large shareholder
86,410
2.66
US$229,850 		86,410 2.66 US$229,850
2024-11-04 2024-11-05 PrS Proposed sale
mDR Ltd

10% Stockholder

Large shareholder
115,400
2.31
US$265,997 		115,400 2.31 US$265,997
Explore more

More insider trading research around CytoMed Therapeutics Ltd

More insider trades in SG
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity